Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review
Titel:
Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review
Auteur:
Anota, Amélie Pozet, Astrid Lemasson, Hervé Cotté, Francois-Emery Falcoz, Antoine Eberst, Guillaume Mouillet, Guillaume Guerzider, Stéphane Charton, Émilie Westeel, Virginie